Zacks Investment Research Upgrades Eurofins Scientific (ERFSF) to Hold

Eurofins Scientific (OTCMKTS:ERFSF) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Friday, Zacks.com reports.

According to Zacks, “Eurofins Scientific SE provides testing services. The company provides food and feed testing, bioanalytical, biopharma, pharma discovery, pharma early development, pharma central laboratory, biopharma product testing, genomic, agroscience, consumer product testing, forensic, environment testing and REACH services. It operates primarily in Benelux, France, Germany, North America, Nordic countries, the United Kingdom, Ireland and internationally. Eurofins Scientific SE is headquartered in Luxembourg. “

A number of other research firms have also recently weighed in on ERFSF. Jefferies Financial Group cut shares of Eurofins Scientific from a “buy” rating to a “hold” rating in a research note on Wednesday, March 20th. ValuEngine cut Eurofins Scientific from a “buy” rating to a “hold” rating in a research note on Monday, December 17th.

Shares of OTCMKTS:ERFSF opened at $399.75 on Friday. Eurofins Scientific has a one year low of $334.00 and a one year high of $575.00.

About Eurofins Scientific

Eurofins Scientific SE, through its subsidiaries, provides various analytical testing services worldwide. The company offers a portfolio of approximately 150,000 analytical methods for evaluating the safety, identity, composition, authenticity, origin, traceability, and purity of biological substances and products, as well as for clinical diagnostic.

Read More: Cost of Capital Explained

Get a free copy of the Zacks research report on Eurofins Scientific (ERFSF)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Eurofins Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eurofins Scientific and related companies with MarketBeat.com's FREE daily email newsletter.